Avances en Biomedicina
Universidad de Los Andes Β· Venezuela, Bolivarian Republic of Β· Est. 2012
β Indexed in the Web of Science Core Collection (ESCI) β Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.
See the official Impact Factor & quartile on the journalβs page βThe Impact Factor & JCR quartile are licensed by Clarivate β we link you to the official source instead of reprinting a number that can go out of date. Source: Clarivate Journal Citation Reports.
Aims & Scope
This publication seeks to promote and disseminate the work carried out by members of the regional, national, and international scientific community, but especially to foster scientific activity in novice researchers at both the undergraduate and postgraduate levels, who constitute the main source of the next generation.
General Information
Submission Info
Ethics & Quality
Think.Check.Submit Compliance
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Subject Classification
Web of Science Categories
Research Topics (OpenAlex)
Frequently asked questions about Avances en Biomedicina
Is Avances en Biomedicina a predatory journal?
PubScope has no integrity flags on record for Avances en Biomedicina: it is indexed in Web of Science, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 62/100. Indexing is a transparency signal, not a guarantee β always confirm fit and policies before submitting.
What is the impact factor of Avances en Biomedicina?
Avances en Biomedicina is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal β including Arts & Humanities and Emerging Sources titles β receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date.
Is Avances en Biomedicina indexed in Scopus and Web of Science?
Avances en Biomedicina is indexed in Web of Science, DOAJ.
What is the aims and scope of Avances en Biomedicina?
This publication seeks to promote and disseminate the work carried out by members of the regional, national, and international scientific community, but especially to foster scientific activity in novice researchers at both the undergraduate and postgraduate levels, who constitute the main source of the next generation.
What is the acceptance rate of Avances en Biomedicina?
Avances en Biomedicina lists a self-reported acceptance rate of approximately 34%. Journal-reported figures can be optimistic β treat it as a rough guide, not a guarantee.
You May Also Like
See all βData updated: 2026-05-26 Β· Sources: SJR, DOAJ, OpenAlex, WoS, Crossref